Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Kodiak Sciences Inc. (KOD) Cash Flow Statement

Kodiak Sciences Inc. (KOD) generated -$158.5M of operating cash flow over the twelve months to 2026-06-30, spent $1.4M on capital expenditure and had free cash flow of -$159.9M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

KODKodiak Sciences Inc.Follow KOD — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
5.5B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-0.03-0.04-0.08-0.18-0.21-0.15-0.12-0.14-0.16
Capital expenditure0.000.000.000.020.040.040.000.00-0.00
Free cash flow-0.03-0.04-0.09-0.20-0.24-0.20-0.12-0.14-0.16
Share repurchases0.00————————
Stock-based compensation0.000.010.030.060.110.090.060.06—

USD billions · SEC XBRL

Kodiak Sciences Inc. — questions

What is Kodiak Sciences Inc.'s operating cash flow?
-$158.5M over the twelve months to 2026-06-30.
How much does Kodiak Sciences Inc. spend on capital expenditure?
$1.4M over the twelve months to 2026-06-30.
What is Kodiak Sciences Inc.'s free cash flow?
-$159.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Kodiak Sciences Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.